Click to read
Mauna Kea Technologies reports full year 2016 financial results and highlights 2017 key priorities
read more
Search Results
Presentation of New Data Demonstrating the Assessment by Cellvizio of Acute Lung Rejection Following Transplant
Data Presented at the 2017 American Thoracic Society International Conference Paris, May 23, 2017 – 5.45 PM CET – Mauna Kea Technologies...
Strong presence of Cellvizio platform at major medical meetings focused on Gastroenterology
Click to read more
Largest Cellvizio Study To Date Demonstrates Near Perfect Correlation with Histology in Key GI Procedures
Cellvizio histologic correlation above 90% for Barrett’s Esophagus, Biliary Strictures, and Pancreatic Cysts procedures Presentation of data...
Mauna Kea Technologies Reports First Quarter 2017 Sales
Click to read
First Cellvizio order placed by UGAP, France’s largest hospital purchasing group, for Avignon’s hospital complex
See the complete press release
New Peer-Reviewed Publication Reports Further External Validation of Unmatched Cellvizio Endomicroscopy Performance and Inter-Observer Agreement in the Characterization of Pancreatic Cysts
Clinical study published in GI Endoscopy this month, performed by the Wexner Medical Center at Ohio State University, a National Pancreas Foundation...
Mauna Kea Technologies confirms its eligibility to the French PEA-PME investment vehicles for 2017/2018
Paris, March 20th 2017 – Mauna Kea Technologies (Euronext : MKEA, FR0010609263 ; OTCQX : MKEAY), inventor of Cellvizio®, the...
Mauna Kea appoints Jennifer F. Tseng, M.D. to Board of Directors
Leading Surgical Oncologist and GI Specialist to Add Clinical Expertise Paris, France and Cambridge, MA, USA, March 13, 2017 - Mauna Kea...
Superiority of Endomicroscopy for the Diagnosis of Gastric Cancer Highlighted in a Peer-Reviewed Publication Comparing Advanced Imaging Technologies
Meta-Analysis Shows Superiority Compared to Other Imaging Modalities Paris, March 2, 2017 – Mauna Kea Technologies (Euronext: MKEA, OTCQX:...
Mauna Kea Technologies Secures a €7.0 million Debt Financing
Paris, February 8, 2017 – Mauna Kea Technologies (Euronext: MKEA, OTCQX: MKEAY) inventor of Cellvizio®, the multidisciplinary confocal...
Mauna Kea Technologies Appoints John Soto As Chief Operating Officer
Addition of Seasoned Medical Device Executive with Decades of Experience in U.S. and Global Markets Strengthens Global Leadership Team Paris,...